Volume 19, Issue 3, Pages (March 2012)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 1, Pages (January 2009)
Advertisements

Volume 23, Issue 2, Pages (February 2016)
Lacidipine Remodels Protein Folding and Ca2+ Homeostasis in Gaucher's Disease Fibroblasts: A Mechanism to Rescue Mutant Glucocerebrosidase  Fan Wang,
Volume 13, Issue 3, Pages (March 2006)
Volume 18, Issue 1, Pages (January 2008)
An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling  Kyle P. Chiang, Sherry Niessen, Alan Saghatelian,
Volume 11, Issue 17, Pages (September 2001)
Finding the Missing Code of RNA Recognition by PUF Proteins
Volume 23, Issue 3, Pages (March 2016)
Volume 44, Issue 3, Pages (November 2011)
Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus  Maya A. Farha, Chris P. Verschoor, Dawn Bowdish,
Volume 7, Issue 3, Pages (March 2010)
Meghal Gandhi, Vérane Achard, Laurent Blanchoin, Bruce L. Goode 
Volume 36, Issue 1, Pages (January 2012)
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 21, Issue 11, Pages (November 2014)
Volume 22, Issue 10, Pages (October 2015)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
m6A Facilitates eIF4F-Independent mRNA Translation
Volume 22, Issue 3, Pages (March 2015)
Volume 19, Issue 18, Pages (September 2009)
Volume 38, Issue 1, Pages (April 2010)
Volume 15, Issue 9, Pages (September 2008)
Volume 20, Issue 12, Pages (December 2013)
Volume 17, Issue 4, Pages (April 2009)
Initiation of RPS2-Specified Disease Resistance in Arabidopsis Is Coupled to the AvrRpt2-Directed Elimination of RIN4  Michael J. Axtell, Brian J. Staskawicz 
DNA Methylation Mediated by a MicroRNA Pathway
Volume 18, Issue 11, Pages (November 2011)
Shiela E. Unkles, Vito Valiante, Derek J. Mattern, Axel A. Brakhage 
Volume 17, Issue 1, Pages (January 2010)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis  Daniel Barkan, Zhen.
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
Volume 23, Issue 11, Pages (November 2016)
Legionella Reveal Dendritic Cell Functions that Facilitate Selection of Antigens for MHC Class II Presentation  Annie L Neild, Craig R Roy  Immunity 
Volume 11, Issue 1, Pages (January 2003)
Volume 66, Issue 5, Pages e4 (June 2017)
Volume 19, Issue 2, Pages (February 2012)
Volume 15, Issue 1, Pages 5-11 (January 2008)
Volume 13, Issue 3, Pages (March 2006)
Volume 19, Issue 6, Pages (December 2003)
Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus
The Central Metabolism Regulator EIIAGlc Switches Salmonella from Growth Arrest to Acute Virulence through Activation of Virulence Factor Secretion  Alain.
Assembly of Desmosomal Cadherins into Desmosomes is Isoform Dependent
Mycobacterium tuberculosis Invasion of Macrophages: Linking Bacterial Gene Expression to Environmental Cues  Kyle H. Rohde, Robert B. Abramovitch, David.
Volume 25, Issue 21, Pages (November 2015)
Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells  Wan Seok Yang,
Volume 26, Issue 4, Pages (May 2007)
Mycobacterium tuberculosis Prevents Inflammasome Activation
Inhibitor Mediated Protein Degradation
Volume 17, Issue 12, Pages (December 2010)
Stress-Induced Phosphorylation of S
Volume 14, Issue 14, Pages (July 2004)
The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure  Masayuki Kohno, Tomohisa Horibe,
Volume 15, Issue 9, Pages (September 2008)
L-DOPA Ropes in tRNAPhe
Volume 19, Issue 5, Pages (May 2012)
Byung-Chang Suh, Jun-Hee Yeon, Cheon-Gyu Park  Cell Chemical Biology 
Volume 22, Issue 11, Pages (November 2015)
Volume 56, Issue 5, Pages (November 1999)
Volume 15, Issue 1, Pages (July 2004)
Analyzing Fission Yeast Multidrug Resistance Mechanisms to Develop a Genetically Tractable Model System for Chemical Biology  Shigehiro A. Kawashima,
A Bacterial Virulence Protein Promotes Pathogenicity by Inhibiting the Bacterium’s Own F1Fo ATP Synthase  Eun-Jin Lee, Mauricio H. Pontes, Eduardo A.
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Volume 18, Issue 11, Pages (November 2011)
Volume 39, Issue 1, Pages (July 2003)
Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho  Aron B. Jaffe, Alan Hall, Anja Schmidt 
Minoru Funakoshi, Robert J. Tomko, Hideki Kobayashi, Mark Hochstrasser 
Volume 19, Issue 8, Pages (April 2009)
Structural Basis of SOSS1 Complex Assembly and Recognition of ssDNA
Presentation transcript:

Volume 19, Issue 3, Pages 372-380 (March 2012) EccA1, a Component of the Mycobacterium marinum ESX-1 Protein Virulence Factor Secretion Pathway, Regulates Mycolic Acid Lipid Synthesis  Shilpa A. Joshi, David A. Ball, Mei G. Sun, Fredric Carlsson, Brigitte Y. Watkins, Nina Aggarwal, Jenna M. McCracken, Kassidy K. Huynh, Eric J. Brown  Chemistry & Biology  Volume 19, Issue 3, Pages 372-380 (March 2012) DOI: 10.1016/j.chembiol.2012.01.008 Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1 EccA1's ATPase Activity Is Needed for ESAT-6 Secretion and Hemolytic Activity (A) EccA1 contains an N-terminal tetratricopeptide repeat (TPR) domain and a C-terminal ATPase domain. (B) Wild-type and plasmid-encoded wild-type or EQ EccA1 are expressed at similar levels. CF, culture filtrate; CL, whole-cell lysate; GroEL, a loading control. (C) EQ-EccA1 expression cannot restore ESAT-6 secretion. Ag85 complex is a loading control, and 8-fold more normalized CF than CL was analyzed in the Ag85 blot, whereas a 1:1 CF:CL ratio was analyzed in all other blots. (D) Wild-type EccA1 complements eccA1::Tn's hemolytic defect, but EQ-EccA1 expression is similar to the buffer control. Averaged data are from three independent experiments and are mean values ± SEM. See also Figure S1. Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 2 EQ EccA1 Interacts More Stably with Lipid Synthases (A) Cytosolic complexes containing EccA1 were isolated and visualized by SDS-PAGE and silver staining. EQ EccA1 coprecipitates more proteins larger than 100 kDa compared to wild-type. (B) Mass spectrometric analyses of coprecipitating proteins identified multiple polyketide synthases as interacting better with EQ EccA1. (C) Immunoblotting of coprecipitation reactions with specific antibodies shows more Pks13 and Mas interacting with EQ EccA1 (left). Quantitated values from two independent experiments are shown (right). (D) All EccA1 variants interact with Pks131–1340, KasB, and KasA as strongly as a control in a two-hybrid experiment, and less well with MmaA4. Percent interaction is calculated from the ratio of colonies on selective plates to those on nonselective plates. Averaged data are from two or more independent experiments, and mean values ± SEM are shown. See also Figure S2 and Tables S1 and S2. Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 3 EccA1 and the FAS-II Mycolic Acid Synthesis System Interact Functionally (A) Radiolabeled and isolated mycolic acid methyl esters were resolved. (B) Quantitation revealed mycolic acid synthesis defects in eccA1::Tn and (eccA1::Tn)/EQ. Averaged data are from three or more independent experiments, and mean values ± SEM are shown (∗∗p ≤ 0.03). Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 4 EQ-EccA1 Expression Also Sensitizes Cells to Ethionamide Stress (A) Left: ethionamide inhibition of mycolic acid synthesis is plotted. (eccA1::Tn)/EQ is most inhibited. Averaged data are from at least four independent experiments, and mean values ± SEM are shown (∗p < 0.05; ∗∗∗p ≤ 0.01). Right: IC50 values for growth-inhibition sensitivity to ethionamide are shown. (eccA1::Tn)/EQ is uniquely sensitized to ethionamide. Mean values ± SEM are averaged data from five independent experiments (∗∗∗p ≤ 0.01; ∗∗∗∗p ≤ 0.002). (B) IC50 values for growth-inhibition sensitivity to two hydrophobic antibiotics, rifampin and erythromycin, are shown. (eccA1::Tn)/EQ is similar to eccA1::Tn in being more resistant to these antibiotics. Mean values ± SEM are averaged data from four or more independent experiments (∗p < 0.05; ∗∗∗p ≤ 0.01). Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 5 EQ EccA1 Further Decreases Virulence and Intracellular Growth (A) An EQ-expressing integrant strain is attenuated for zebrafish killing (∗∗∗∗p ≤ 0.002 compared to wild-type, log-rank test; n ≥ 5 for each strain). (B) All strains grew similarly in 7H9 media. (C) eccA1::Tn is defective for intracellular growth in bone marrow-derived macrophages. Wild-type EccA1 complements this defect, but EQ EccA1 worsens growth. Data are averaged from three independent experiments (∗∗p ≤ 0.03; ∗∗∗p ≤ 0.01; ∗∗∗∗p ≤ 0.002). Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 6 A Model of EccA1's Interaction with FAS-II Proteins For efficient mycolic acid production, EccA1 must interact with FAS-II components such as Pks13, KasB, and KasA (A–C), and release them in an ATP hydrolysis-linked manner to the rest of FAS-II (D). (eccA1::Tn)/EQ is further sensitized to mycolic acid stress, relative to eccA1::Tn, because it has a lower amount of fully functioning Pks13, KasB, and KasA, important in (D). EccA1's interactions with these partner proteins are shown to be direct and exclusive here, but other mycobacterial proteins may aid these interactions or be part of these complexes. Three ATPs (shown in red) are bound to hexameric EccA1 here, but the real number is unknown. Chemistry & Biology 2012 19, 372-380DOI: (10.1016/j.chembiol.2012.01.008) Copyright © 2012 Elsevier Ltd Terms and Conditions